Who is sponsoring NCT06073535?

NCT06073535 is sponsored by University of Naples.

What drugs are being tested in NCT06073535?

Interventions in NCT06073535: Extraction of mandibular third molar, i-PRF.

What condition does NCT06073535 study?

NCT06073535 studies Molar, Third, Postoperative Complications.

Is NCT06073535 still recruiting?

NCT06073535 is currently status unknown. Last updated 21 December 2023.

Last reviewed 2023-12-21 · How we verify

NCT06073535

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Use of Injectable-Platelet Rich Fibrin (i-PRF) in the Lower Third Molar Extraction

Status unknown NA Last updated 21 December 2023

What this trial tests

NA trial testing Extraction of mandibular third molar in Molar, Third in 40 participants. Status unknown.

Timeline

27 February 2023

Primary endpoint
4 September 2023

29 December 2023

Quick facts

Lead sponsor	University of Naples
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	prevention
Enrollment	40
Start date	27 February 2023
Primary completion	4 September 2023
Estimated completion	29 December 2023
Sites	1 location across Italy

Drugs / interventions tested

Extraction of mandibular third molar
i-PRF

Conditions studied

Molar, Third — all drugs for Molar, Third →
Postoperative Complications — all drugs for Postoperative Complications →

Sponsor

University of Naples

Who can join

Adults 18 to 35, any sex, with Molar, Third or Postoperative Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Lower third molar extraction is one of the most frequently performed surgical procedures in dentistry. Common sequelae, including pain, swelling and trismus, can severely affect patients' quality of life during the immediate postoperative period. The aim of this randomized-controlled trial is to clinically evaluate the reduction of lower third molar extraction-related complications, such as swelling and pain, and wound healing, following submucosal infiltration of injectable platelet rich fibrin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Molar, Third

Currently open trials in the same condition.

NCT05924191 — Preventive Effect of Photobiomodulation in the Postoperative Period of Extractions of Retained Lower Third Molars · NA · recruiting

Other University of Naples trials

Trials by the same sponsor.

NCT07305298 — Mirabegron in Patients With Age-Related Macular Degeneration · not yet recruiting
NCT06629662 — Robotic Versus Laparoscopic Sleeve Gastrectomy · NA · recruiting
NCT06184906 — Preventing Celiac Disease by Weaning With Mediterranean Diet · Phase 3 · not yet recruiting
NCT06173492 — Platelet Rich Fibrin (PRF) in Socket Preservation Technique · NA · unknown
NCT06122428 — Efficacy of Riboflavin-Enhanced Hyaluronic Acid Eye Drops in Treating Dry Eye Disease · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06073535 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Naples
Last refreshed: 21 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06073535.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing